11:11 AM EDT, 10/09/2025 (MT Newswires) -- Rocket Doctor AI ( AIRDF ) shares rose 4.3% Thursday after its wholly-owned digital health platform and marketplace, Rocket Doctor, received advisory services and funding of up to $75,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) and funding of up to $25,000 from the CanExport SMEs program.

The company said funding from NRC IRAP will be used to develop secure communications functionality, and funding from the CanExport SMEs program will be used to speed-up product innovation and U.S. market growth. It added that the NRC IRAP support will be dedicated to the development of a secure, PHIPA- and HIPAA-compliant messaging feature for Rocket Doctor's care platform.

"By ensuring our platform is fully compliant with PHIPA, HIPAA, and Ontario Health standards, we are not only serving Ontario patients, but also ensuring readiness across Canada, as well as for the U.S. health systems, Medicaid / Medicare plans, and Commercial partners," said Rocket Doctor chief executive William Cherniak.

Shares of the company were last seen up $0.03 at $0.73 on the Canadian Securities Exchange.

Price: 0.73, Change: +0.03, Percent Change: +4.29